SMTL ID : 3lp3.1 (2 other biounits)

p15 HIV RNaseH domain with inhibitor MK3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

2 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 5 residues within 4Å: Chain A: D.19, G.20, D.125 Ligands: MN.2, LP9.3 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.19, A:D.125, H2O.1 MN.2: 5 residues within 4Å: Chain A: D.19, E.54, D.74 Ligands: MN.1, LP9.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.19, A:E.54, A:D.74

1 x LP9: 3-[4-(diethylamino)phenoxy]-6-(ethoxycarbonyl)-5,8-dihydroxy-7-oxo-7,8-dihydro-1,8-naphthyridin-1-ium(Non-covalent)

LP9.3: 11 residues within 4Å: Chain A: D.19, R.24, Q.51, E.54, D.74, A.114, H.115, D.125, S.129 Ligands: MN.1, MN.2 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.115

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H.P. et al., Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors. J.Virol. (2010)

Release Date

2010-06-09

Peptides

p15: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

p15

Related Entries With Identical Sequence